Admitting Mistake News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  Covid-19 Vaccine stocks – which includes U.S.-listed pharma and biotech companies. The theme is up by about 640% year-to-date versus about 13% for the S&P 500. [Updated 11/11/2020] Why Pfizer’s Vaccine Data Is Good News For Moderna While Pfizer‘s (NYSE: PFE) surprisingly strong initial Covid-19 vaccine efficacy readout likely marks the beginning of the end of the Covid-19 pandemic, it probably doesn’t mean too much for Pfizer stock, given the limited potential profits and challenges with distribution. In fact, we think that the strong data from the vaccine – which is developed...

  Covid-19 Vaccine stocks – which includes U.S.-listed pharma and biotech companies. The theme is up by about 640% year-to-date versus about 13% for the S&P 500. [Updated 11/11/2020] Why Pfizer’s Vaccine Data Is Good News For Moderna While Pfizer‘s (NYSE: PFE) surprisingly strong initial Covid-19 vaccine efficacy readout likely marks the beginning of the end of the Covid-19 pandemic, it probably doesn’t mean too much for Pfizer stock, given the limited potential profits and challenges with distribution. In fact, we think that the strong data from the vaccine – which is developed...

As we've said before, Moderna's Covid-19 vaccine is likely to emerge as the most sought after vaccine in developed markets, considering its stellar efficacy rates and relative ease of storage.